
### [NCIT:C4033](http://purl.obolibrary.org/obo/NCIT_C4033)
**Label:** Clear Cell Renal Cell Carcinoma

**Subclasses:** [NCIT:C36261](http://purl.obolibrary.org/obo/NCIT_C36261) (Non-Hereditary Clear Cell Renal Cell Carcinoma), [NCIT:C36260](http://purl.obolibrary.org/obo/NCIT_C36260) (Hereditary Clear Cell Renal Cell Carcinoma), [NCIT:C35853](http://purl.obolibrary.org/obo/NCIT_C35853) (Grade 3 Clear Cell Renal Cell Carcinoma), [NCIT:C35852](http://purl.obolibrary.org/obo/NCIT_C35852) (Grade 2 Clear Cell Renal Cell Carcinoma), [NCIT:C35851](http://purl.obolibrary.org/obo/NCIT_C35851) (Grade 1 Clear Cell Renal Cell Carcinoma), [NCIT:C35854](http://purl.obolibrary.org/obo/NCIT_C35854) (Grade 4 Clear Cell Renal Cell Carcinoma), 

**Class expressions from DL-Learner:**

- [NCIT:C61143](http://purl.obolibrary.org/obo/NCIT_C61143) (Delicate Vascular Network Formation) 53.57%
- [NCIT:C53974](http://purl.obolibrary.org/obo/NCIT_C53974) (Non-Hereditary Lesion) 53.57%
- [NCIT:C39795](http://purl.obolibrary.org/obo/NCIT_C39795) (Loss of Chromosome 14q) 53.57%
- [NCIT:C39786](http://purl.obolibrary.org/obo/NCIT_C39786) (Bilateral Disease) 53.57%
- [NCIT:C38328](http://purl.obolibrary.org/obo/NCIT_C38328) (Unfavorable Clinical Outcome) 53.57%
- [NCIT:C36687](http://purl.obolibrary.org/obo/NCIT_C36687) (VHL Gene Inactivation) 53.57%
- [NCIT:C36649](http://purl.obolibrary.org/obo/NCIT_C36649) (EGFR Gene Amplification) 53.57%
- [NCIT:C36636](http://purl.obolibrary.org/obo/NCIT_C36636) (Loss of Chromosome 9p) 53.57%
- [NCIT:C36586](http://purl.obolibrary.org/obo/NCIT_C36586) (Loss of Chromosome 3) 53.57%
- [NCIT:C36329](http://purl.obolibrary.org/obo/NCIT_C36329) (TP53 Gene Inactivation) 53.57%
- [NCIT:C18261](http://purl.obolibrary.org/obo/NCIT_C18261) (VHL Gene) 53.57%
- Thing 53.04%
- [NCIT:C41454](http://purl.obolibrary.org/obo/NCIT_C41454) (Cystic Change) 32.44%
- [NCIT:C7057](http://purl.obolibrary.org/obo/NCIT_C7057) (Disease, Disorder or Finding) 28.59%
- [NCIT:C3910](http://purl.obolibrary.org/obo/NCIT_C3910) (Molecular Abnormality) 26.85%


